BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15207833)

  • 1. Secondary accumulation of gangliosides in lysosomal storage disorders.
    Walkley SU
    Semin Cell Dev Biol; 2004 Aug; 15(4):433-44. PubMed ID: 15207833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.
    McGlynn R; Dobrenis K; Walkley SU
    J Comp Neurol; 2004 Dec; 480(4):415-26. PubMed ID: 15558784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.
    Breiden B; Sandhoff K
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).
    Sandhoff R; Sandhoff K
    Adv Neurobiol; 2023; 29():333-390. PubMed ID: 36255681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-system disorders of glycosphingolipid and ganglioside metabolism.
    Xu YH; Barnes S; Sun Y; Grabowski GA
    J Lipid Res; 2010 Jul; 51(7):1643-75. PubMed ID: 20211931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent.
    Gondré-Lewis MC; McGlynn R; Walkley SU
    Curr Biol; 2003 Aug; 13(15):1324-9. PubMed ID: 12906793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
    Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
    J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
    Jeyakumar M; Butters TD; Dwek RA; Platt FM
    Neuropathol Appl Neurobiol; 2002 Oct; 28(5):343-57. PubMed ID: 12366816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM2 ganglioside and pyramidal neuron dendritogenesis.
    Walkley SU; Siegel DA; Dobrenis K
    Neurochem Res; 1995 Nov; 20(11):1287-99. PubMed ID: 8786814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of Glycosphingolipids and Their Role in the Pathophysiology of Lysosomal Storage Disorders.
    Ryckman AE; Brockhausen I; Walia JS
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobiology and cellular pathogenesis of glycolipid storage diseases.
    Walkley SU
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):893-904. PubMed ID: 12803923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipocalin-type prostaglandin D synthase is up-regulated in oligodendrocytes in lysosomal storage diseases and binds gangliosides.
    Mohri I; Taniike M; Okazaki I; Kagitani-Shimono K; Aritake K; Kanekiyo T; Yagi T; Takikita S; Kim HS; Urade Y; Suzuki K
    J Neurochem; 2006 May; 97(3):641-51. PubMed ID: 16515539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis.
    Jabs S; Quitsch A; Käkelä R; Koch B; Tyynelä J; Brade H; Glatzel M; Walkley S; Saftig P; Vanier MT; Braulke T
    J Neurochem; 2008 Aug; 106(3):1415-25. PubMed ID: 18498441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.
    Prinetti A; Prioni S; Chiricozzi E; Schuchman EH; Chigorno V; Sonnino S
    Neurochem Res; 2011 Sep; 36(9):1654-68. PubMed ID: 21207141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal Glycosphingolipid Storage Diseases.
    Breiden B; Sandhoff K
    Annu Rev Biochem; 2019 Jun; 88():461-485. PubMed ID: 31220974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease.
    Walkley SU; Thrall MA; Haskins ME; Mitchell TW; Wenger DA; Brown DE; Dial S; Seim H
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):536-44. PubMed ID: 16150124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult-onset lysosomal storage disease in a Schipperke dog: clinical, morphological and biochemical studies.
    Knowles K; Alroy J; Castagnaro M; Raghavan SS; Jakowski RM; Freden GO
    Acta Neuropathol; 1993; 86(3):306-12. PubMed ID: 8213091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of ganglioside and asialoglycosphingolipid antigens in adult T-cell leukemia cells.
    Suzuki Y; Hirabayashi Y; Matsumoto N; Kato H; Hidari K; Tsuchiya K; Matsumoto M; Hoshino H; Tozawa H; Miwa M
    Jpn J Cancer Res; 1987 Oct; 78(10):1112-20. PubMed ID: 2890614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular pathology of lysosomal diseases.
    Cox TM; Cachón-González MB
    J Pathol; 2012 Jan; 226(2):241-54. PubMed ID: 21990005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.